Stock Events

Stock Events

Quantum BioPharma 

$3.24
155
+$0.29+9.83% Friday 20:00
+$0.12+3.7%Friday 23:51After hours

Statistics

Day High
3.22
Day Low
3
52W High
21
52W Low
2.07
Volume
2,005
Avg. Volume
-
Mkt Cap
136.08
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-3.42
-2.34
-1.25
-0.17
Expected EPS
-0.50253005
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-26.18MNet Income

Analyst Ratings

8.00Average Price Target
The highest estimate is 8.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QNTM. It's not an investment recommendation.
Amazon
13
AMZN
NVIDIA
13
NVDA
Microsoft
12
MSFT
AMD
12
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap1.25B
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, making it a direct competitor in the cannabis market.
Tilray Brands
TLRY
Mkt Cap631.5M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, competing in the same market as FSD Pharma.
Canopy Growth
CGC
Mkt Cap449.07M
Canopy Growth Corporation operates in the cannabis and hemp business, directly competing with FSD Pharma in the cannabis industry.
Aurora Cannabis
ACB
Mkt Cap253.87M
Aurora Cannabis is engaged in the production, distribution, and sale of cannabis products, competing in the same industry as FSD Pharma.
Green Thumb Industries
GTBIF
Mkt Cap1.56B
Green Thumb Industries is involved in the cultivation, sale, and distribution of cannabis products, making it a competitor in the cannabis industry alongside FSD Pharma.

About

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
Show more...
CEO
Zeeshan Saeed
Employees
7
Country
Canada
ISIN
CA74764Y2050
WKN
000A3E2LR

Listings

F
DE
0K91.F
STU
DE
0K91.STU
MU
DE
0K9.MU
CN
CA
QNTM.CN

0 Comments

Share your thoughts

FAQ

What is Quantum BioPharma stock price today?▼
The current price of QNTM is $3.24 USD — it has increased by +9.83% in the past 24 hours. Watch Quantum BioPharma stock price performance more closely on the chart.
What is Quantum BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Quantum BioPharma stocks are traded under the ticker QNTM.
Is Quantum BioPharma stock price growing?▼
QNTM stock has risen by +5.37% compared to the previous week, the month change is a +11.72% rise, over the last year Quantum BioPharma has showed a -53.9% decrease.
What is Quantum BioPharma market cap?▼
Today Quantum BioPharma has the market capitalization of 136.08
When is the next Quantum BioPharma earnings date?▼
Quantum BioPharma is going to release the next earnings report on November 06, 2026.
What were Quantum BioPharma earnings last quarter?▼
QNTM earnings for the last quarter are -0.46 USD per share, whereas the estimation was -0.41 USD resulting in a -11.58% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quantum BioPharma revenue for the last year?▼
Quantum BioPharma revenue for the last year amounts to 0 USD.
What is Quantum BioPharma net income for the last year?▼
QNTM net income for the last year is -26.18M USD.
How many employees does Quantum BioPharma have?▼
As of September 05, 2026, the company has 7 employees.
In which sector is Quantum BioPharma located?▼
Quantum BioPharma operates in the Health & Wellness sector.
When did Quantum BioPharma complete a stock split?▼
The last stock split for Quantum BioPharma was on October 27, 2025 with a ratio of 1:1.
Where is Quantum BioPharma headquartered?▼
Quantum BioPharma is headquartered in Toronto, Canada.